BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9925662)

  • 1. The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds.
    Pullinger CR; Gaffney D; Gutierrez MM; Malloy MJ; Schumaker VN; Packard CJ; Kane JP
    J Lipid Res; 1999 Feb; 40(2):318-27. PubMed ID: 9925662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.
    Pullinger CR; Hennessy LK; Chatterton JE; Liu W; Love JA; Mendel CM; Frost PH; Malloy MJ; Schumaker VN; Kane JP
    J Clin Invest; 1995 Mar; 95(3):1225-34. PubMed ID: 7883971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
    Wenham PR; Henderson BG; Penney MD; Ashby JP; Rae PW; Walker SW
    Atherosclerosis; 1997 Mar; 129(2):185-92. PubMed ID: 9105560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia.
    Rabès JP; Varret M; Devillers M; Aegerter P; Villéger L; Krempf M; Junien C; Boileau C
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E76-82. PubMed ID: 11031227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Miserez AR; Keller U
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects.
    Arnold KS; Balestra ME; Krauss RM; Curtiss LK; Young SG; Innerarity TL
    J Lipid Res; 1994 Aug; 35(8):1469-76. PubMed ID: 7989871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering.
    Chatterton JE; Schlapfer P; Bütler E; Gutierrez MM; Puppione DL; Pullinger CR; Kane JP; Curtiss LK; Schumaker VN
    Biochemistry; 1995 Jul; 34(29):9571-80. PubMed ID: 7626627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding.
    Gaffney D; Pullinger CR; O'Reilly DS; Hoffs MS; Cameron I; Vass JK; Kulkarni MV; Kane JP; Schumaker VN; Watts GF; Packard CJ
    Clin Chim Acta; 2002 Jul; 321(1-2):113-21. PubMed ID: 12031600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia.
    Giammanco A; Spina R; Fayer F; Barbagallo CM; Noto D; Cefalù AB; Averna MR
    Intern Med J; 2021 Apr; 51(4):585-590. PubMed ID: 33890362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
    Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
    Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
    Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of an exon 3 mutation (Trp66-->Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family.
    Levy E; Minnich A; Cacan SL; Thibault L; Giroux LM; Davignon J; Lambert M
    Biochem Mol Med; 1997 Feb; 60(1):59-69. PubMed ID: 9066982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100.
    Raungaard B; Heath F; Hansen PS; Brorholt-Petersen JU; Jensen HK; Faergeman O
    Clin Chem; 2000 Feb; 46(2):224-33. PubMed ID: 10657378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco.
    Chater R; Aït Chihab K; Rabès JP; Varret M; Chabraoui L; El Jahiri Y; Adlouni A; Boileau C; Kettani A; El Messal M
    Clin Chim Acta; 2006 Nov; 373(1-2):62-9. PubMed ID: 16806138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
    März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
    J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies.
    Krul ES; Parhofer KG; Barrett PH; Wagner RD; Schonfeld G
    J Lipid Res; 1992 Jul; 33(7):1037-50. PubMed ID: 1431583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.
    Haddad L; Day IN; Hunt S; Williams RR; Humphries SE; Hopkins PN
    J Lipid Res; 1999 Jun; 40(6):1113-22. PubMed ID: 10357843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
    Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
    Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
    Weisgraber KH; Innerarity TL; Newhouse YM; Young SG; Arnold KS; Krauss RM; Vega GL; Grundy SM; Mahley RW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9758-62. PubMed ID: 3200853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.